Trimetrexate Glucuronate Patent Expiration
Trimetrexate Glucuronate was first introduced by Medimmune Oncology Inc
Trimetrexate Glucuronate Patents
Given below is the list of patents protecting Trimetrexate Glucuronate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Neutrexin | US6017922 | Thermally stable trimetrexates and processes for producing the same |
May 18, 2018
(Expired) | Medimmune Oncology |
Trimetrexate Glucuronate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List